United Therapeutics
UTHR
#1025
Rank
A$33.39 B
Marketcap
A$778.59
Share price
-5.19%
Change (1 day)
15.99%
Change (1 year)

EPS for United Therapeutics (UTHR)

EPS in 2026 (TTM): A$44.69

According to United Therapeutics's latest financial reports the company's current EPS (TTM) is A$43.52. In 2025 the company made an earnings per share (EPS) of A$43.38 an increase over its 2024 EPS that were of A$38.02.

EPS history for United Therapeutics from 2013 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A$44.693.03%
2025A$43.3814.1%
2024A$38.0225.59%
2023A$30.2731.54%
2022A$23.0151.18%
2021A$15.22-9.1%
2020A$16.74-581.4%
2019A-$3.48-117.79%
2018A$19.5542.11%
2017A$13.75-40.93%
2016A$23.2813.45%
2015A$20.52104.29%
2014A$10.05100.29%
2013A$5.02

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
A$1.09-97.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$42.95-1.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
A-$2.98-106.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A-$3.74-108.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Cardinal Health
CAH
A$10.43-76.02%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$4.60-89.44%๐Ÿ‡ฌ๐Ÿ‡ง UK
Cytokinetics
CYTK
A-$10.38-123.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$0.91-97.92%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel